Clinical trial · Interventional
Feasibility of VMAT and CBCT for Head and Neck Carcinomas
Feasibility of Volumetric Modulated Arc Therapy and Cone-Beam Computed Tomography for Head and Neck Carinomas: Analysis of Clinical Throughput and Patient Reported Outcomes.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This will be a prospective longitudinal study describing clinical throughput metrics and patient reported quality of life outcome measures for patients undergoing Volumetric modulated arc therapy (VMAT) with and without Cone-beam computed tomography (CBCT) for head and neck carcinoma at the British Columbia Cancer Agency. 1. VMAT for the treatment of patients with HNC will provide opportunities for image-guided radiotherapy using CBCT online correction to reduce systematic and random error. 2. Analysis of patient reported quality of life outcomes during VMAT, with and without CBCT acquisition, will be hypothesis generating.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Carcinoma | Head and Neck Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| VMAT with CBCT | Radiation | — | UNRESOLVED |
| VMAT with kV-ray | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- VMAT with CBCT
- description
- Volumetric modulated arc therapy (VMAT) with cone-beam computed tomography position (CBCT) verification
- interventionNames
- Radiation: VMAT with CBCT
- type
- ACTIVE_COMPARATOR
- label
- VMAT with kV-ray
- description
- Volumetric modulation arc therapy (VMAT) with kV-ray position verification
- interventionNames
- Radiation: VMAT with kV-ray
Primary outcomes (2)
- measure
- Clinical efficiency for volumetric modulated arc therapy (VMAT) delivery
- timeFrame
- After patient treated
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Months
Show eligibility criteria text
Inclusion Criteria: * age greater than 18 years * undergoing radical radiation therapy for head and neck carcinoma at the BC Cancer Agency Exclusion Criteria: * treatment being offered is not for curative intent * patient has received previous radiation for head and neck cancer * patient has systemic lupus erythematosis or scleroderma * patients has other autoimmune connective tissue disorders
References
Publications (0)
Data not yet available